Cargando…
Efficacy of Denosumab Therapy Following Treatment with Bisphosphonates in Women with Osteoporosis: A Cohort Study
Denosumab is a human monoclonal antibody that neutralizes RANKL, a cytokine able to interact with the RANK receptor on preosteoclasts and osteoclasts, decreasing their recruitment and differentiation, leading to a decreased bone resorption. The aim of this observational real-life study was to analyz...
Autores principales: | Marocco, Chiara, Zimatore, Giovanna, Mocini, Edoardo, Fornari, Rachele, Iolascon, Giovanni, Gallotta, Maria Chiara, Bimonte, Viviana Maria, Baldari, Carlo, Lenzi, Andrea, Migliaccio, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916792/ https://www.ncbi.nlm.nih.gov/pubmed/33579002 http://dx.doi.org/10.3390/ijerph18041728 |
Ejemplares similares
-
Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects
por: Emerenziani, Gian Pietro, et al.
Publicado: (2016) -
Response to: Comment on “Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects”
por: Emerenziani, Gian Pietro, et al.
Publicado: (2017) -
Response to: Comment #2 on “Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects”
por: Emerenziani, Gian Pietro, et al.
Publicado: (2018) -
Nutritional and physical activity issues in frailty syndrome during the COVID-19 pandemic
por: Massari, Maria Chiara, et al.
Publicado: (2023) -
Is obesity in women protective against osteoporosis?
por: Migliaccio, Silvia, et al.
Publicado: (2011)